Lv11
95 积分 2021-05-13 加入
Multispecific drugs herald a new era of biopharmaceutical innovation
3天前
已完结
Lilly pays US$1.2 billion for Ventyx and its oral anti-inflammatories
6天前
已关闭
The race to reset autoimmune diseases
6天前
已完结
PROTAC 2.0: Expanding the frontiers of targeted protein degradation
14天前
已完结
Targeted protein degradation: from mechanisms to clinic
14天前
已完结
Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation
14天前
已关闭
Advances and challenges of estrogen receptor-targeted agents in breast cancer
14天前
已完结
Targeted protein degradation for cancer therapy
22天前
已完结
The targeted protein degradation landscape
22天前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
1个月前
已完结
皖公网安备34019202002308
